Market Tracker

07/01 5:16pm ET

Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

358.50
Delayed Data
As of Jul 01
 +9.27 / +2.65%
Today’s Change
329.09
Today|||52-Week Range
605.93
-33.96%
Year-to-Date
Wall Street set for best week since late 2014 as stocks rebound
Jul 01 / FT.com - Paid Partner Content
Forget Stem Cell Stocks: Here Are 3 Clinical-Stage Biotechs to Buy Instead
Jun 28 / MotleyFool.com - Paid Partner Content
Here's Why Regeneron Pharmaceuticals Inc Is Down 35% This Year
Jul 01 / MotleyFool.com - Paid Partner Content
3 Biotech Stocks to Buy Now for the Long Haul
Jun 25 / MotleyFool.com - Paid Partner Content
Esperion Therapeutics Inc Sinks After FDA Says, "Ask Us in 2019"
Jun 29 / MotleyFool.com - Paid Partner Content
Company News for June 23, 2016
Jun 23 / Zacks.com - Paid Partner Content
Pfizer's PCSK9 Inhibitor Tops Two Additional Phase III Studies
Jun 29 / Zacks.com - Paid Partner Content
Warren Buffett's Favorite High-Yield Dividend Stock
Jun 22 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close349.23
Today’s open349.00
Day’s range348.43 - 359.89
Volume777,083
Average volume (3 months)949,270
Market cap$36.7B
Dividend yield--
Data as of 4:00pm ET, 07/01/2016

Growth & Valuation

Earnings growth (last year)+79.80%
Earnings growth (this year)-10.23%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)+45.55%
P/E ratio56.9
Price/Sales15.24
Price/Book10.00

Competitors

 Today’s
change
Today’s
% change
QQuintiles Transnatio...+1.54+2.36%
ALNYAlnylam Pharmaceutic...+5.95+10.72%
CRLCharles River Labora...+0.86+1.04%
ICLRICON PLC+0.63+0.90%
Data as of 4:02pm ET, 07/01/2016

Financials

Next reporting dateAugust 2, 2016
EPS forecast (this quarter)$2.60
Annual revenue (last year)$4.1B
Annual profit (last year)$636.1M
Net profit margin15.50%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Leonard S. Schleifer
Chief Financial Officer &
Senior VP-Finance
Robert E. Landry
Corporate headquarters
Tarrytown, New York

Forecasts